Highlights

• Analysis of China's pharmaceutical exports and internationalisation landscape 
• Reflections on pharmaceutical internalisation-export pathways for proprietary branded formulations
• Strategic considerations for peptide drug global expansion
• Collaborative internationalisation—advanced models for Chinese pharmaceutical companies "going global"
•  Leveraging Hong Kong and Macau advantages to bring Chinese innovative drugs to the world
• Exploration of API-formulation integration
• Discussion on globalisation pathways for complex

Agenda:

09:30 - 10:00   Sign in

10:00 - 10:10 Opening remark & introduction of speakers

10:10 - 10:30 China's pharmaceutical foreign trade landscape and globalization trends

10:30 - 11:00  Internationalization strategies for formulations: self-export 2.0 under new circumstances

11:00 - 11:30 Partnership models & value restructuring in API internationalization

11:30 - 12:00 Dual-strategy approach: CDMO services in Europe & self-selected product strategies

13:00 - 13:30 Sign-in

13:30 - 14:0 Exploration of the global path for complex formulations

14:00 - 14:30 International opportunities & challenges for Chinese pharma: polypeptide formulation case studies

14:30 - 15:00 Global expansion strategies for biosimilars

15:00 - 15:30 European market entry pathways & strategies for pharmaceuticals

15:30 - 16:00 Emerging market expansion strategies for formulations

15:30 - 16:00 TBD

16:00 - 17:00 Panel discussion: new opportunities and challenges for formulation internationalisation under new circumstances

NEW: This session features AI English translation

Highlights:

• New breakthroughs in efficient, low-irritation functional skincare formulation
• Biomimetic lipids advancing barrier repair for sensitive skin
• Scientific skincare driving precise anti-aging solutions
• Antioxidant ingredients enabling effective whitening and anti-aging solutions
• Innovative applications of plant-based ingredients under natural, healthy, and environmentally friendly concepts

Agenda:

10:00 - 10:05 Opening remarks

10:05 - 10:10 CPHI Leadership address          

10:10 - 10:40 Society Report & JDSCT: Introduction to the International journal of skin science and cosmetic technology

10:40 - 11:10 Skin science-driven development of cosmetic ingredients

11:10 - 11:40 Clinical validation strategies for cosmetic safety & efficacy

11:40 - 12:10 TBD

12:10 - 13:30 Lunch break

13:30 - 14:00 Innovative efficacy assessment technologies for product differentiation

14:00 - 14:30 Herbal Wisdom Meets Tech Decoding: Medical-Cosmetic Translation in Efficacy Skincare

14:30 - 15:00 Functional  cosmetics: raw material breakthroughs, formulation innovations, and global market trends

15:00 - 15:30 TBD

15:30 - 15:45 Inauguration ceremony of the Cosmetics Professional Committee of the China Pharmaceutical University Guangdong - Hong Kong - Macau Alumni Association

15:45 - 16:00 Award presentation ceremony          

16:00 - 16:10 Conference closing summary

Agenda:

10:00 - 10:05 Opening remarks

10:05 - 10:10 Welcome speech

10:10 - 10:40 Planning, design and implementation strategies for smart pharmaceutical factories

10:40 - 11:10 Technological trends and regulatory logic of smart pharmaceutical manufacturing

11:10 - 11:40 New ecology of R&D in Chinese pharmaceutical enterprises: insights and solutions

11:40 - 12:30 Offline activity for industrial pharmaceutical formulation enthusiasts

13:00 - 13:25 The road to industrialization of new pharmaceutical formulations

13:25 - 13:55 TBD

13:55 - 14:25 TBD

14:25 - 14:55 TBD

14:55 - 15:20 Application of innovative low-temperature spray technology in the pharmaceutical industry

15:20 - 15:40 Development of new antibiotics driven by artificial intelligence for combating drug - resistant pathogens

15:40 - 16:00 Introduction to the cLNA oligonucleotide technology platform

16:00 - 16:20 Is the modernisation of traditional Chinese medicine a false proposition?

Agenda:

13:30 - 13:50 Analysis of the application prospects and successful case sharing of micro - needle transdermal formulations

13:50 - 14:20 The path to success of Chinese-style innovative drugs

14:20 - 14:40 Research, development, and industrialisation of high-end complex injection formulations

14:40 - 15:00 Commercial value, development strategies, and implementation pathways of sustained release new drugs

15:00 - 15:20 Full chain CDMO deep synergy: dual empowerment of technology transfer and process deepening

15:20 - 15:50 TBD

15:50 - 16:10 TBD

NEW: This session features AI English translation

Agenda:

10:00 - 10:02 Opening remarks

10:02 - 10:05 Opening remarks by the leader of Shenzhen Pharmaceutical and Medical Device Industry Outbound Alliance

10:05 - 10:25 Global restructuring of the biopharmaceutical market

10:25 - 10:45 The internationalisation path of Indian pharmaceutical enterprises

10:45 - 11:05 MENA - a new blue ocean for Chinese pharmaceutical enterprises

11:05 - 11:25 Exploring opportunities and choices in South America pharmaceutical markets

11:25 - 12:15 Panel discussion: practical experience in emerging markets and innovative opportunities brought by new productivity

NEW: This session features AI English translation

Agenda:

13:30 - 14:10 Discussion on the reconstruction of pharmaceutical packaging material quality system, production compliance, and risk control under new regulations

14:10 - 14:50 Interpretation of pharmaceutical packaging material standards in the 2025 edition of Chinese Pharmacopoeia

14:50 - 15:30 Selection strategies for drug delivery devices in complex formulations

15:30 - 16:10 Case sharing: challenges and coping strategies for packaging materials and drug delivery devices in the process of Chinese pharmaceutical internationalisation

NEW: This session features AI English translation

Highlights 

• How can DTP business stakeholders ensure compliance under stricter medical insurance supervision?
• Exploration and practice of internet healthcare platforms facilitating DTP prescription circulation
• New opportunities in the pharmaceutical market: jointly creating a blue ocean in the out-of-hospital market
• The surge in prescription circulation: new development opportunities for clinical agents/representatives
• How national negotiation, medical insurance, and self-pay products can expand in the out-of-hospital prescription circulation market?

Agenda:

09:30 - 10:00 Compliance strategies for DTP stakeholders amid stricter regulations

10:00 - 10:30 Digital healthcare platforms: innovations in DTP prescription circulation

10:30 - 11:00 New opportunities in the pharmaceutical market: creating new strategies for the Out-of-Hospital market

11:00 - 11:30 New opportunities for clinical agents/representatives in prescription circulation

11:30 - 12:00 Expanding out-of-hospital prescription markets for nationally negotiated, insurance-covered, and self-pay products

NEW: This session features AI English translation

Highlights:                                                                                       

• Consumer willingness-to-pay thresholds: how to transform scientific value into commercial value?
• The cost-efficiency paradox in flexible manufacturing beyond mass personalization: scaling truly individualized production
• Doctors, nutritionists, AI: who will dominate the final decision-making power for personalized nutrition?
• Consumer cognition and trust: how to break the stereotype that "precision nutrition =  gimmick"? 

Agenda:

13:00 - 13:30 Women's whole-life health management: from genetic screening to precision nutrition solutions 

13:30 - 14:00 Insights into the challenges and breakthroughs of precision nutrition supplements from the industrial chain perspective                                                                        

14:00 - 14:30 Precision nutrition in functional baking: market implementation lessons from ligao foods wholesome bakery workshop                                     

14:30 - 15:00 Health effects of plant proteins and innovative applications of high-protein full-nutrition foods                                                                                

15:00 - 16:00 Panel discussion: Breaking barriers in precision nutritioncommercialisation

Agenda:

9:30 - 9:35 Opening remarks

9:35 - 10:05 Regulatory oversight of aesthetic medical devices                                                                                   

10:05 - 10:35 The journey and outlook of the pioneer in type A recombinant humanized collagen protein's global expansion

10:35 - 11:05 Next-Gen aesthetic R&D: engineering unparalleled product differentiation       

11:05 - 11:35 Regenerative medicine-driven R&D: Asian beauty innovation from concept to commercialization  

11:35 - 12:05 Navigating injectable aesthetics approval: regulatory strategy & review priorities     

Process Innovation and Quality Control Session

14:00 - 14:30 What pain points can silk fibroin address in the aesthetic medicine field?  

14:30 - 15:00 Profhilo five-point facelift   

15:00 - 15:30 Injection material requirements for different clinical indications in aesthetic treatments (TBD)     

15:30 - 16:00 The evolution of recombinant collagen: bio-self-crosslinking Gels   

16:00 - 16:30 Novel materials for beauty anti-aging & regenerative repair: Based on recombinant human elastin and fusion matrix proteins 

Synthetic Biology and Regenerative Materials Session

10:00 - 10:30 The innovative development of injection aesthetic medicine --- regenerative aesthetic medicine   

10:30 - 11:00 AI-driven recombinant collagen design: accelerating development and application of anti-aging biomaterials                                                               

11:00 - 11:30 The application of biomedical new materials in aesthetic medicine (TBD)  

11:30 - 12:00 Medical principles of regenerative materials and injection techniques

Highlights:

The conference will deeply focus on three core dimensions: policy and regulations, production technology, and quality control, while integrating pharmaceutical industry development trends in the Greater Bay Area through three thematic sub-forums. Simultaneously, the meeting will invite regulatory experts, corporate executives, and technical pioneers to gather together, creating the pharmaceutical industry's first intelligent exchange platform that connects the entire chain of research and development, production, and quality control.

Session One: Implementation of the 2025 Edition of the Chinese Pharmacopoeia

Date: 2 September / Location:  Forum Area B, Booth: 8C80

09:30 - 10:00 Interpretation and implementation strategies of changes in aseptic standards related to the 25th edition of the Pharmacopoeia

10:00 - 10:30 Inspection and control of new aseptic microorganisms added in the 25th edition of the Pharmacopoeia

10:30 - 11:00 How to meet the requirements of the new Pharmacopoeia and GMP for production equipment?

11:00 - 11:30 How to ensure the integrity of aseptic environmental monitoring data under new regulations?

Session Two: Empowering Pharmaceutical Quality Control with Laboratory Scientific Instruments

Date: 2 September / Location:  Forum Area B, Booth: 8C80

13:30 - 14:00 How can laboratory scientific instruments efficiently empower key quality control links in pharmaceutical production?

14:00 - 14:30 Nanocarrier-promoted tumor treatment: quality control of targeted delivery and controlled release

14:30 - 15:00 Strengthening laboratory safety management to build a lifeline for pharmaceutical quality

15:00 - 15:30 Practical tools for quality control in pharmaceutical

15:30 - 16:00 Panel discussion

Session Three: Analysis and Application Practice of Hot Topics in International Pharmaceutical Production Supervision Policies

Date: 3 September / Location:  Forum Area B, Booth: 8C80

10:00 - 10:40 Requirements for the maintenance and entry into the globalization path of drugs and quality system management

10:40 - 11:20 Key points of formulation and management of pharmaceutical production pollution control strategy

11:20 - 12:00 Sharing of key points of environmental monitoring in pharmaceutical production clean areas

Agenda:

9:20 - 9:30 Opening remark

9:30 - 10:10 Asian pharmaceutical market - regional exploration and decomposition

10:10 - 10:40 Analysis of the Malaysian pharmaceutical market and cooperation opportunities

10:40 - 11:10 Indian pharmaceutical market: potential impacts of tightening policies

11:10 - 11:40 Practice in exploring the Vietnamese pharmaceutical market

11:40 - 12:00 Access policies for Chinese health products in the Indonesian market

12:00 - 12:15 Panel discussion: exploration of "Variables in the Asian market and sustainable strategies"

Agenda:

9:30 - 9:35 Host opening

9:35 - 9:40 Opening remarks

9:40 - 10:00 Strategic development of functional food products

10:00 - 10:20 Omega-3 in chronic disease management: current status and prospects Omega-3

10:20 - 10:40 Research and development of gut health and probiotics

10:40 - 11:00 Precision nutrition for healthy aging in the big data era

11:00 - 11:30 Interactive discussion